INTRODUCTION: Antiplatelet agents, 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors (statin drugs), angiotensin converting enzyme (ACE) inhibitors, and β-adrenergic …

Objective The aim was to summarise the evidence from published epidemiological studies
investigating the efficacy of statin therapy on long term survival in patients after abdominal …

The cardiovascular field is still searching for a treatment for abdominal aortic aneurysms
(AAA). This inflammatory disease often goes undiagnosed until a late stage and associated …

Background: Abdominal aortic aneurysm (AAA) remains one of the hallmark pathologies in
vascular surgery and an area of intense research interest. Treatment options have …

Abdominal aortic aneurysm (AAA) rupture is an important cause of death in adults. Currently,
the only treatment for AAA is open or endovascular surgical repair. In most parts of the …

Worldwide about 20 million people have an abdominal aortic aneurysm (AAA) and rupture
leads to approximately 200 000 deaths annually. To prevent rupture, early detection and …

Abdominal aortic aneurysm (AAA) is a vascular disease with high mortality. Because of the
lack of effective medications to stop or reverse the progression of AAA, surgical operation …

In this single center, retrospective cohort study we wished to compare early and total
mortality for all patients treated for abdominal aortic aneurysms (AAA) with open surgery …

Background Patients with abdominal aortic aneurysms are at high risk of cardiovascular
events. Although statin therapy is indicated for most of these patients, no specific …

Introduction Literature regarding pharmacological manipulation of aneurysm development
and progression is abundant; however studies looking at preventing rupture are sparse …